Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Endocrinol ; 589: 112250, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-38663485

ABSTRACT

The most common form of hypercortisolism is iatrogenic Cushing's syndrome. Lipodystrophy and metabolic disorders can result from the use of exogenous glucocorticoids (GC). Adipocytes play an important role in the production of circulating exosomal microRNAs, and knockdown of Dicer promotes lipodystrophy. The aim of this study is to investigate the effect of GCs on epididymal fat and to assess their influence on circulating microRNAs associated with fat turnover. The data indicate that despite the reduction in adipocyte volume due to increased lipolysis and apoptosis, there is no difference in tissue mass, suggesting that epididymal fat pad, related to animal size, is not affected by GC treatment. Although high concentrations of GC have no direct effect on epididymal microRNA-150-5p expression, GC can induce epididymal adipocyte uptake of microRNA-150-5p, which regulates transcription factor Ppar gamma during adipocyte maturation. In addition, GC treatment increased lipolysis and decreased glucose-derived lipid and glycerol incorporation. In conclusion, the similar control and GC epididymal fat mass results from increased dense fibrogenic tissue and decreased adipocyte volume induced by the lipolytic effect of GC. These findings demonstrate the complexity of epididymal fat. They also highlight how this disease alters fat distribution. This study is the first in a series published by our laboratory showing the detailed mechanism of adipocyte turnover in this disease.


Subject(s)
Adipocytes , Epididymis , Glucocorticoids , Lipolysis , MicroRNAs , Male , Animals , MicroRNAs/metabolism , MicroRNAs/genetics , Epididymis/drug effects , Epididymis/metabolism , Epididymis/pathology , Adipocytes/drug effects , Adipocytes/metabolism , Glucocorticoids/adverse effects , Glucocorticoids/pharmacology , Lipolysis/drug effects , Mice , Apoptosis/drug effects , Mice, Inbred C57BL , PPAR gamma/metabolism , PPAR gamma/genetics
2.
J Physiol Sci ; 68(2): 165-174, 2018 Mar.
Article in English | MEDLINE | ID: mdl-28083734

ABSTRACT

Beta-hydroxy-beta-methylbutyrate (HMB), a leucine metabolite, enhances the gain of skeletal muscle mass by increasing protein synthesis or attenuating protein degradation or both. The aims of this study were to investigate the effect of HMB on molecular factors controlling skeletal muscle protein synthesis and degradation, as well as muscle contractile function, in fed and fasted conditions. Wistar rats were supplied daily with HMB (320 mg/kg body weight diluted in NaCl-0.9%) or vehicle only (control) by gavage for 28 days. After this period, some of the animals were subjected to a 24-h fasting, while others remained in the fed condition. The EDL muscle was then removed, weighed and used to evaluate the genes and proteins involved in protein synthesis (AKT/4E-BP1/S6) and degradation (Fbxo32 and Trim63). A sub-set of rats were used to measure in vivo muscle contractile function. HMB supplementation increased AKT phosphorylation during fasting (three-fold). In the fed condition, no differences were detected in atrogenes expression between control and HMB supplemented group; however, HMB supplementation did attenuate the fasting-induced increase in their expression levels. Fasting animals receiving HMB showed improved sustained tetanic contraction times (one-fold) and an increased muscle to tibia length ratio (1.3-fold), without any cross-sectional area changes. These results suggest that HMB supplementation under fasting conditions increases AKT phosphorylation and attenuates the increased of atrogenes expression, followed by a functional improvement and gain of skeletal muscle weight, suggesting that HMB protects skeletal muscle against the deleterious effects of fasting.


Subject(s)
Ligases/metabolism , Ubiquitin/metabolism , Valerates/pharmacology , Animals , Carrier Proteins/metabolism , Fasting/metabolism , Leucine/metabolism , Male , Muscle Contraction/drug effects , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Phosphorylation/drug effects , Rats , Rats, Wistar
3.
Sci Rep ; 7(1): 15591, 2017 Nov 15.
Article in English | MEDLINE | ID: mdl-29142304

ABSTRACT

This study aimed to investigate the consequences of maternal exposure to iodine excess (IE; 0.6 mg NaI/L) throughout pregnancy and lactation on the hypothalamus-pituitary-thyroid axis of the male offspring in adulthood. Maternal IE exposure increased hypothalamic Trh mRNA expression and pituitary Tsh expression and secretion in the adult male offspring. Moreover, the IE-exposed offspring rats presented reduced thyroid hormones levels, morphological alterations in the thyroid follicles, increased thyroid oxidative stress and decreased expression of thyroid differentiation markers (Tshr, Nis, Tg, Tpo, Mct8) and thyroid transcription factors (Nkx2.1, Pax8). Finally, the data presented here strongly suggest that epigenetic mechanisms, as increased DNA methylation, augmented DNA methyltransferases expression, hypermethylation of histone H3, hypoaceylation of histones H3 and H4, increased expression/activity of histone deacetylases and decreased expression/activity of histone acetyltransferases are involved in the repression of thyroid gene expression in the adult male offspring. In conclusion, our results indicate that rat dams' exposure to IE during pregnancy and lactation induces primary hypothyroidism and triggers several epigenetic changes in the thyroid gland of their male offspring in adulthood.


Subject(s)
Hypothyroidism/physiopathology , Iodine/adverse effects , Maternal Exposure/adverse effects , Pituitary Gland/drug effects , Animals , Breast Feeding , Female , Humans , Hypothyroidism/chemically induced , Iodide Peroxidase/genetics , Lactation/drug effects , Pituitary Gland/growth & development , Pituitary Gland/physiopathology , Pregnancy , Rats , Thyroid Gland/drug effects , Thyroid Gland/physiopathology , Thyroid Hormones/metabolism
4.
Life Sci ; 191: 17-23, 2017 Dec 15.
Article in English | MEDLINE | ID: mdl-28993146

ABSTRACT

L-Arginine has emerged as an important supplement for athletes and non-athletes in order to improve performance. Arginine has been extensively used as substrate for nitric oxide synthesis, leading to increased vasodilatation and hormonal secretion. However, the chronic consumption of arginine has been shown to impair insulin sensitivity. In the present study, we aimed to evaluate whether chronic arginine supplementation associated with exercise training would have a beneficial impact on insulin sensitivity. We, therefore, treated Wistar rats for 4weeks with arginine, associated or not with exercise training (treadmill). We assessed the somatotropic activation, by evaluating growth hormone (GH) gene expression and protein content in the pituitary, as well is GH concentration in the serum. Additionally, we evaluate whole-body insulin sensitivity, by performing an insulin tolerance test. Skeletal muscle morpho-physiological parameters were also assessed. Insulin sensitivity was impaired in the arginine-treated rats. However, exercise training reversed the negative effects of arginine. Arginine and exercise training increased somatotropic axis function, muscle mass and body weight gain. The combination arginine and exercise training further decreased total fat mass. Our results confirm that chronic arginine supplementation leads to insulin resistance, which can be reversed in the association with exercise training. We provide further evidence that exercise training is an important tool to improve whole-body metabolism.


Subject(s)
Arginine/adverse effects , Dietary Supplements/adverse effects , Insulin Resistance , Muscle, Skeletal/physiology , Animals , Gene Expression Regulation , Growth Hormone/analysis , Growth Hormone/blood , Growth Hormone/genetics , Insulin/metabolism , Male , Physical Conditioning, Animal , Physical Exertion , Rats, Wistar
5.
Endocr Connect ; 6(7): 510-521, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28814477

ABSTRACT

Adequate maternal iodine consumption during pregnancy and lactation guarantees normal thyroid hormones (TH) production, which is crucial to the development of the fetus. Indeed, iodine deficiency is clearly related to maternal hypothyroidism and deleterious effects in the fetal development. Conversely, the effects of iodine excess (IE) consumption on maternal thyroid function are still controversial. Therefore, this study aimed to investigate the impact of IE exposure during pregnancy and lactation periods on maternal hypothalamus-pituitary-thyroid axis. IE-exposed dams presented reduced serum TH concentration and increased serum thyrotropin (TSH) levels. Moreover, maternal IE exposure increased the hypothalamic expression of Trh and the pituitary expression of Trhr, Dio2, Tsha and Tshb mRNA, while reduced the Gh mRNA content. Additionally, IE-exposed dams presented thyroid morphological alterations, increased thyroid oxidative stress and decreased expression of thyroid genes/proteins involved in TH synthesis, secretion and metabolism. Furthermore, Dio1 mRNA expression and D1 activity were reduced in the liver and the kidney of IE-treated animals. Finally, the mRNA expression of Slc5a5 and Slc26a4 were reduced in the mammary gland of IE-exposed rats. The latter results are in accordance with the reduction of prolactin expression and serum levels in IE-treated dams. In summary, our study indicates that the exposure to IE during pregnancy and lactation induces primary hypothyroidism in rat dams and impairs iodide transfer to the milk.

6.
Thyroid ; 26(10): 1488-1498, 2016 10.
Article in English | MEDLINE | ID: mdl-27461375

ABSTRACT

BACKGROUND: Iodine is essential for thyroid hormone synthesis and is an important regulator of thyroid function. Chronic iodine deficiency leads to hypothyroidism, but iodine excess also impairs thyroid function causing hyperthyroidism, hypothyroidism, and/or thyroiditis. This study aimed to investigate the underlying mechanisms by which exposure to chronic iodine excess impairs pituitary-thyroid axis function. METHODS: Male Wistar rats were treated for two months with NaI (0.05% and 0.005%) or NaI+NaClO4 (0.05%) dissolved in drinking water. Hormone levels, gene expression, and thyroid morphology were analyzed later. RESULTS: NaI-treated rats presented high levels of iodine in urine, increased serum thyrotropin levels, slightly decreased serum thyroxine/triiodothyronine levels, and a decreased expression of the sodium-iodide symporter, thyrotropin receptor, and thyroperoxidase mRNA and protein, suggesting a primary thyroid dysfunction. In contrast, thyroglobulin and pendrin mRNA and protein content were increased. Kidney and liver deiodinase type 1 mRNA expression was decreased in iodine-treated rats. Morphological studies showed larger thyroid follicles with higher amounts of colloid and increased amounts of connective tissue in the thyroid of iodine-treated animals. All these effects were prevented when perchlorate treatment was combined with iodine excess. CONCLUSIONS: The present data reinforce and add novel findings about the disruption of thyroid gland function and the compensatory action of increased thyrotropin levels in iodine-exposed animals. Moreover, they draw attention to the fact that iodine intake should be carefully monitored, since both deficient and excessive ingestion of this trace element may induce pituitary-thyroid axis dysfunction.


Subject(s)
Gene Expression Regulation/drug effects , Iodine/poisoning , Pituitary Gland/drug effects , Poisoning/physiopathology , Thyroid Gland/drug effects , Thyroiditis/etiology , Animals , Antidotes/therapeutic use , Iodide Peroxidase/antagonists & inhibitors , Iodide Peroxidase/genetics , Iodide Peroxidase/metabolism , Iodine/chemistry , Iodine/urine , Male , Perchlorates/therapeutic use , Pituitary Gland/metabolism , Pituitary Gland/pathology , Pituitary Gland/physiopathology , Poisoning/metabolism , Poisoning/pathology , Poisoning/prevention & control , RNA, Messenger/metabolism , Rats, Wistar , Receptors, Thyrotropin/antagonists & inhibitors , Receptors, Thyrotropin/genetics , Receptors, Thyrotropin/metabolism , Renal Elimination , Sodium Compounds/therapeutic use , Sodium Iodide/administration & dosage , Symporters/antagonists & inhibitors , Symporters/genetics , Symporters/metabolism , Thyroid Gland/metabolism , Thyroid Gland/pathology , Thyroid Gland/physiopathology , Thyrotropin/blood , Thyrotropin/metabolism , Thyroxine/blood , Thyroxine/metabolism , Toxicity Tests, Chronic , Toxicokinetics , Triiodothyronine/blood , Triiodothyronine/metabolism
7.
Growth Horm IGF Res ; 24(6): 268-70, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25312793

ABSTRACT

Under physical activity a wide variety of cellular metabolic products and hormones are altered in the blood stream, including lactate, a metabolite of pyruvate reduction, and growth hormone (GH). Although a positive correlation between lactate and GH seems to exist during exercise, the role of lactate as a mediator of GH production has never been investigated. Thus, the aim of this study was to investigate whether lactate could activate the somatotropic axis and stimulate GH synthesis/release, contributing to the enhanced somatotropic activity described in exercise conditions. Male adult Wistar rats were acutely treated with sodium lactate [15 or 150µmols, i.p.] at the beginning of the active period (Zeitgeber time 13-14), and euthanized by decapitation 30, 60 and 120min after the injections. Serum GH concentration were determined using ELISA and Gh and Igf-1 mRNA expressions were quantified by qPCR. Serum GH concentration and Gh mRNA expression were increased 30min after lactate injections for both treatments. However, [15µmols] of lactate injection kept GH serum concentration chronically high throughout the experimental period. Igf-1 mRNA expression was increased only 60min after challenge with [15µmols] of lactate, time point which corresponded to 30min after the serum GH peak. The present results led us to conclude that lactate mediates activation of the somatotropic axis, therefore emphasizing its possible role on GH synthesis/release, and further indicating that it could play a part on the increased GH secretion observed in exercise conditions.


Subject(s)
Growth Hormone/blood , Insulin-Like Growth Factor I/metabolism , Lactic Acid/pharmacology , Liver/metabolism , Pituitary Gland/metabolism , Animals , Enzyme-Linked Immunosorbent Assay , Growth Hormone/genetics , Insulin-Like Growth Factor I/genetics , Liver/drug effects , Male , Pituitary Gland/drug effects , RNA, Messenger/genetics , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...